Omlonti Eye Drops Dosage
Generic name: OMIDENEPAG ISOPROPYL 0.02mg in 1mL
Dosage form: ophthalmic solution
Drug class: Ophthalmic glaucoma agents
Medically reviewed by Drugs.com. Last updated on Apr 21, 2025.
Recommended Dosage
The recommended dosage is one drop in the affected eye(s) once daily in the evening.
Administration Instructions
Gently shake the bottle prior to administration. If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart. Contact lenses should be removed prior to the administration of Omlonti, and may be reinserted 15 minutes after administration.
More about Omlonti (omidenepag isopropyl ophthalmic)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: ophthalmic glaucoma agents
Patient resources
Professional resources
Related treatment guides
See also:
Xalatan
Xalatan (latanoprost) is used to treat certain types of glaucoma. Includes Xalatan side effects ...
Latanoprost ophthalmic
Latanoprost ophthalmic is used for glaucoma, open angle, intraocular hypertension
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Lumigan
Lumigan is used to treat open angle glaucoma. Learn about side effects, interactions and indications.
Combigan
Combigan (brimonidine and timolol) is used to treat glaucoma or ocular hypertension. Includes ...
Alphagan P
Alphagan P is used to treat glaucoma or ocular hypertension (high pressure inside the eye). Learn ...
Vyzulta
Vyzulta is used for glaucoma, open angle, glaucoma/intraocular hypertension
Zioptan
Zioptan (tafluprost eye drops) is used to reduce elevated intraocular pressure in patients with ...
Tafluprost ophthalmic
Tafluprost ophthalmic is used for glaucoma, open angle, glaucoma/intraocular hypertension ...
Bimatoprost ophthalmic
Bimatoprost ophthalmic is used for glaucoma, open angle, intraocular hypertension
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
